Darnitsa Bromhexine is a medicine which is applied at cough and catarrhal diseases. For sekretolitichesky therapy at the sharp and chronic bronchopulmonary diseases which are followed by difficulty of an otkhozhdeniye of a phlegm.
Structure
- 1 tablet contains Bromhexine of a hydrochloride 8 mg;
- excipients: lactose, potato starch, calcium stearate.
Contraindication
Hypersensitivity to medicine components; peptic ulcer of a stomach and duodenum; diseases of a respiratory system which course is followed by formation of a large number of a liquid phlegm.
Route of administrationMedicine to apply
inside, irrespective of meal. Duration of reception depends on indications and the course of the disease and is established individually. to Adults and children 14 years on 1-2 tablets (8-16 mg) 3 times a day are more senior than
. A course of treatment - 4-5 days.
to Children aged from 6 up to 14 years and also the patient with body weight less than 50 kg: on 1 tablet (4-8 mg) 3 times a day. A course of treatment - 4-5 days.
Feature of application
With care to use medicament to the patients having bronchial asthma and to patients with a renal or heavy liver failure (i.e. to increase intervals between receptions or to reduce a dose).
In a sharp renal failure needs to consider a possibility of accumulation of metabolites of Bromhexine in a liver.
Pregnant women
appoint medicine byduring pregnancy taking into account a ratio advantage for mother/risk for a fruit.
Children
apply Medicine to children aged from 6 years. To children up to 6 years to apply in other dosage forms.
Drivers
Are not present messages that medicine can affect ability to drive the car or to work with mechanisms.
Overdose
Dispepsichesky frustration, nausea, vomiting, diarrhea, dizziness, headache, diplopia, ataxy, slight metabolic acidosis, Tachypnea. No chronic toxic action on the person is revealed.
Side effects
from nervous system: a headache (as migraine), dizziness.
from the respiratory system, bodies of a thorax and mediastinum: strengthening of cough, bronchospasm, disorders of breath, respiratory distress.
from digestive tract: the dispepsichesky phenomena, nausea, vomiting, diarrhea, an abdominal pain, exacerbation of a peptic ulcer of a stomach and duodenum, tranzitorny increase in activity of aminotransferases in blood serum.
Storage conditionsto Store
in original packing at a temperature not above 25 °C. To store out of children's reach.
Characteristics | |
Active ingredients | Bromhexine |
Amount of active ingredient | 8 mg |
Applicant | Darnitsa |
Code of automatic telephone exchange | R05CB02 Bromhexine |
Interaction with food | It doesn't matter |
Light sensitivity | Not sensitive |
Market status | Generic-generic |
Origin | Chemical |
Prescription status | Without prescription |
Primary packing | planimetric cellular packing |
Producer | DARNITSA CIAO PHARMACEUTICAL. FIRM |
Quantity in packing | 50 tablets |
Release form | tablets for internal use |
Route of administration | Oral |
Sign | Domestic |
Storage temperature | from 5 °C to 25 °C |
Trade name | Bromhexine |
Bromhexin-Darnitsa of the tab. of 8 mg No. 50
- Product Code: 178715
- In Stock
- Ready to ship
-
$15.87